Home Press Release AIIn Pathology Market Size Projected to Reach $1,140.55 million by 2034 | 23.8%

AIIn Pathology Market Size Projected to Reach $1,140.55 million by 2034 | 23.8%

22 Jul, 2026

According to Straits Research, the global AI in pathology market size was valued at $166.41 million in 2025 and is expected to reach $1,140.55 million by 2034, registering a CAGR of 23.8% during the forecast period (2026–2034)

The AI in pathology market is segmented based on offering, technology, application, end use, and region. Some of the insights provided in the report are highlighted below:

  • The hardware segment is expected to be the fastest growing with a CAGR of 25.16% during the forecast period.
  • North America is expected to lead the market during the forecast period, owing to the growing prevalence of cancer and the availability of a strong digital framework.
  • Healthcare providers, such as laboratory officials, are adopting AI-supported pathology solutions for rising volumes.
  • China is expected to lead the Asia Pacific market by integrating AI tools to address the shortage of pathologists.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision-makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market.

Market Segments

  1. By Offering
    1. Hardware
      1. Imaging Scanners
      2. AI-enabled Microscopes
      3. Digital Pathology Systems
    2. Software
      1. Workflow Management
      2. Data Management
      3. Image Analysis
      4. Predictive Analytics Tools
    3. Services
  2. By Technology
    1. Machine Learning
    2. Computer Vision-based Image Analysis
    3. Natural Language Processing 
  3. By Application
    1. Drug Discovery
    2. Disease Diagnosis & Prognosis
    3. Training & Education
  4. By End Use
    1. Pharmaceutical & Biotechnology Companies
    2. Hospital & Reference Laboratories
    3. Academic & Research Institutes
  5. By Region
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM